Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.
Hypercalcemia with adult T-cell leukemia (ATL) is chiefly caused by an excessive production by tumor cells of parathyroid hormone-related protein (PTHrP). We have previously reported hypercalcemic patients with solid tumors to excrete a large amount of the C-terminal fragments of PTHrP (C-PTHrP) into their urine. To elucidate whether PTHrP production correlates with or predicts the development of hypercalcemia, we studied the urinary excretion of C-PTHrP in 36 ATL patients. The urinary excretion of C-PTHrP was in the normal range (< 0.40 nmol equivalent to PTHrP (109-141)/g creatinine) in HTLV-1-positive carriers (n 3), ATL patients in complete remission (n 2) and chronic type ATL patients (n 2). It was marginally increased in seven patients in partial remission, and gradually increased as the disease progressed. In 20 patients who died without or with hypercalcemia, it was increased to 1.98 +/- 0.69 (n 9) and 7.6 +/- 2.1 nmol/g creatinine (mean +/- SD, n 11, P < 0.01), respectively. Urinary C-PTHrP excretion was significantly correlated with serum calcium and LDH levels as well as with CD25-positive cells in the peripheral blood. In four patients whose urinary excretion had been serially determined, it increased prior to the development of hypercalcemia. The findings suggest the urinary excretion of C-PTHrP to be of use as a predictor of the development of hypercalcemia in ATL patients. In ATL patients whose urinary excretion of C-PTHrP is progressively increasing, the serum calcium concentration should be carefully monitored to prevent hypercalcemic crisis.
Imamura
H
H
Internal Medicine, Kagoshima Municipal Hospital.
Koreeda
Y
Y
Okadome
T
T
Tara
M
M
Niina
K
K
Shizume
K
K
Ohsumi
K
K
Sato
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000652:urine*; D002118:Calcium / Q000097:blood; D005260:Female; D015368:Human T-lymphotropic virus 1; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D015461:Leukemia, Prolymphocytic, T-Cell / Q000150:complications / Q000652:urine; D015458:Leukemia, T-Cell / Q000097:blood / Q000150:complications* / Q000652:urine*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000652:urine*; D010281:Parathyroid Hormone / Q000652:urine*; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000032:analysis*; D015375:Receptors, Interleukin-2 / Q000032:analysis; D012074:Remission Induction
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D015375:Receptors, Interleukin-2; D007770:L-Lactate Dehydrogenase; D002118:Calcium